Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426954 · ClinicalTrials.gov registry record · NA
BFRT MPFL and ACL Reconstruction Rehab
A NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation, sponsored by Richard Watson, PT.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT05426954 is a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation that has completed, run by Richard Watson, PT. The registered enrollment target is 43 participants, above the 37-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05426954, a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Medial Patellar Femoral Ligament Reconstruction Rehabilitation, has completed, sponsored by Richard Watson, PT.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood flow restrictive (BFR) therapy following MPFL or ACL reconstruction rehabilitation. Specific Aim 1: Test whether maintaining BFR cuff inflation or deflating between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction. Hypothesis 1: Subjects in the deflate BFR protocol group will have significantly greater quadriceps strength, symmetric leg symmetry index on a battery of functional tests and PROs as compared to the non-deflate group. Specific Aim 2: Compare whether maintaining BFR cuff inflation or deflating between exercises results in reduced pain, improved exercise tolerance, and patient-reports outcomes (PRO) after MPFL or ACL reconstruction. Hypothesis 2: Subjects in the deflated BFR protocol group will report significantly less pain and greater exercise tolerance during exercise with significantly improved knee related PRO scores.
Conditions Studied
Interventions
- OTHER Rehabilitation utilizing blood flow restrictive therapy
Study Locations (1)
Kentucky
- University of Kentucky Sports Rehabilitation - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05426954
The ClinicalTrials.gov registry entry for NCT05426954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (16% higher). The listed sponsor is Richard Watson, PT, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anterior Cruciate Ligament Reconstruction Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Rehabilitation utilizing blood flow restrictive therapy is the first listed.
NCT05426954 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05426954 about?
NCT05426954 is a clinical study titled "BFRT MPFL and ACL Reconstruction Rehab". Blood flow restrictive (BFR) therapy following MPFL or ACL reconstruction rehabilitation. Specific Aim 1: Test whether maintaining BFR cuff inflation or deflating between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction. Hypothesis 1: Subjec...
What is the current status of trial NCT05426954?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-06-29. Estimated completion is 2023-07-28.
What conditions does trial NCT05426954 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation, Medial Patellar Femoral Ligament Reconstruction Rehabilitation.
What interventions are being tested in trial NCT05426954?
The interventions under investigation include: Rehabilitation utilizing blood flow restrictive therapy (OTHER).
Who is sponsoring clinical trial NCT05426954?
This trial is sponsored by Richard Watson, PT, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05426954 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation
RECRUITING · NA
-
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
RECRUITING · NA
-
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
RECRUITING · NA
-
Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction
RECRUITING · Phase 1
Explore more on PlainTrial
Anterior Cruciate Ligament Reconstruction Rehabilitation
All registered trials for this condition
Medial Patellar Femoral Ligament Reconstruction Rehabilitation
All registered trials for this condition
Kentucky
All trials with a study site in Kentucky
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.